Cardiac resynchronization therapy (CRT) is considered a beneficial and disease-modifying treatment in appropriately selected heart failure (HF) patients. It reduces morbidity and mortality, reverses ...

Read the Market Summary Here @- Global Cardiac Resynchronization Therapy (CRT) Devices Market Size Booming at Healthy CAGR of 8.4% to Touch USD 11.6 Billion by 2030 Global Cardiac Resynchronization ...

If you want to operate on local time faster, recovery from jet lag requires the resynchronization of human circadian systems ...

New research finds that on extremely hot days, people with implanted defibrillators face nearly triple the odds for a ...

A team of researchers from Mayo Clinic Health System in La Crosse has made significant strides in cardiac care by exploring ...

Optimal follow-up of patients with CRT plays an important role in ensuring that patients will derive maximum benefit from this treatment. In addition to ensuring adequate therapy delivery by ...

In the new study, researchers analyzed health data for 2,313 adults in more than 100 U.S. cities who had an implantable ...

Medically reviewed by Richard N. Fogoros, MD Symptoms of left-sided heart failure can include chest pain, fatigue, shortness ...

A NIH study shows men are three times more likely to receive cardiac resynchronization therapy to control arrhythmia, for example. The public and private sectors can do much more to improve women’s ...

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

Metso has rebranded its Planet Positive initiative as "Metso Plus" to support customers’ sustainability goals and align with ...

Thousands of Americans with heart trouble have small implanted defibrillators, to help regulate their heartbeat and keep ...